Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026 - Summary - MDSpire
Advertisement
Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026
Experts across Baptist Health Herbert Wertheim Cancer Institute and Eugene M. & Christine E. Lynn Cancer Institute will present new radiation oncology research and clinical expertise at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 26-30, 2026, in Boston.
To present new radiation oncology research and clinical expertise at the 2026 ASTRO Annual Meeting.
Approach:
Research Areas: The research covers MR-guided adaptive radiation therapy, radiopharmaceutical therapy, proton therapy, stereotactic radiosurgery, and treatment timing for various complex cancers.
Clinical Focus: Studies address significant clinical needs in brain metastases, prostate cancer, pancreaticobiliary cancer, colorectal cancer, breast cancer, oropharyngeal cancer, anal cancer, and pediatric and young adult lymphoma.
Key Findings:
Analysis of PSMA PET-derived biomarkers in metastatic castration-resistant prostate cancer.
Early intracranial radiotherapy improves survival in breast cancer brain metastases.
Ablative MR-guided adaptive radiotherapy is effective for anatomically challenging tumors.
Outcomes following proton craniospinal irradiation for solid tumor leptomeningeal metastasis.
Interpretation:
Conclusion:
Baptist Health researchers will present multiple oral and poster presentations, contributing to advancements in radiation oncology.
